Patent applications and USPTO patent grants for ChronTech Pharma AB.The latest application filed is for "injection needle and device".
Patent | Date |
---|---|
Injection Needle And Device App 20170216573 - Sallberg; Matti ;   et al. | 2017-08-03 |
Immunogen Platform App 20170058003 - Sallberg; Matti ;   et al. | 2017-03-02 |
Immunogenic Compositions For Inhibiting Hepatitis D Virus App 20160324954 - Sallberg; Matti ;   et al. | 2016-11-10 |
Injection Needle And Device App 20160235928 - Sallberg; Matti ;   et al. | 2016-08-18 |
Treatment Of Hepatitis D Virus Infections By Redirection Of T Cells App 20160228531 - Sallberg; Matti ;   et al. | 2016-08-11 |
Compositions And Methods That Enhance An Immune Response App 20150252084 - Sallberg; Matti ;   et al. | 2015-09-10 |
Glycosylated specificity exchangers Grant 9,079,962 - Sallberg , et al. July 14, 2 | 2015-07-14 |
Immunogen Platform App 20150051388 - Sallberg; Matti ;   et al. | 2015-02-19 |
Immunogen platform Grant 8,883,169 - Sallberg , et al. November 11, 2 | 2014-11-11 |
Simple Vaccines From Dna Launched Suicidal Flaviviruses App 20140286985 - Sallberg; Matti ;   et al. | 2014-09-25 |
Injection Needle And Device App 20140121587 - Sallberg; Matti ;   et al. | 2014-05-01 |
Glycosylated Specificity Exchangers App 20140081004 - Sallberg; Matti ;   et al. | 2014-03-20 |
Glycosylated specificity exchangers Grant 8,658,179 - Sallberg , et al. February 25, 2 | 2014-02-25 |
Compositions And Methods That Enhance An Immune Response App 20130202554 - SALLBERG; MATTI ;   et al. | 2013-08-08 |
Compositions and methods that enhance an immune response Grant 8,445,663 - Sallberg , et al. May 21, 2 | 2013-05-21 |
Glycosylated Specificity Exchangers App 20130041131 - Sallberg; Matti ;   et al. | 2013-02-14 |
T Cell Receptors Specific For Immunodominant Ctl Epitopes Of Hcv App 20130011375 - Chen; Margaret Sallberg | 2013-01-10 |
Codon-optimzed Hepatitis B Virus Core Antigen (hbcag) App 20130012865 - Sallberg; Matti ;   et al. | 2013-01-10 |
Glycosylated specificity exchangers Grant 8,303,956 - Sallberg , et al. November 6, 2 | 2012-11-06 |
Immunogen platform Grant 8,258,275 - Sallberg , et al. September 4, 2 | 2012-09-04 |
Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene App 20120208870 - Sallberg; Matti | 2012-08-16 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 8,163,547 - Sallberg April 24, 2 | 2012-04-24 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 8,163,712 - Sallberg April 24, 2 | 2012-04-24 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 8,158,602 - Sallberg April 17, 2 | 2012-04-17 |
Compositions And Methods That Enhance An Immune Response App 20120039842 - Sallberg; Matti ;   et al. | 2012-02-16 |
Immunogen Platform App 20120010394 - Sallberg; Matti ;   et al. | 2012-01-12 |
Immunogen platform Grant 8,071,561 - Sallberg , et al. December 6, 2 | 2011-12-06 |
Hepatitis C virus non-structural NS3/4A fusion gene Grant 7,968,697 - Sallberg June 28, 2 | 2011-06-28 |
Immunogen Platform App 20110150922 - Sallberg; Matti ;   et al. | 2011-06-23 |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene Grant 7,943,149 - Sallberg May 17, 2 | 2011-05-17 |
Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene App 20110081381 - Sallberg; Matti | 2011-04-07 |
Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene App 20110082287 - Sallberg; Matti | 2011-04-07 |
Hepatitis C Virus Codon Optimized Non-structural Ns3/4a Fusion Gene App 20110065174 - Sallberg; Matti | 2011-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.